NCT02968732View on ClinicalTrials.gov

Cystoscopic Evaluation Predicting pT0 Urothelial Carcinoma of the Bladder

NAActive, not recruitingINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

November 11, 2016

Primary Completion Date

August 19, 2019

Study Completion Date

April 1, 2027

Conditions
Urothelial Carcinoma
Interventions
PROCEDURE

Radical Cystectomy

Trial Locations (1)

19111

Fox Chase Cancer Center, Philadelphia

All Listed Sponsors
collaborator

Temple University

OTHER

lead

Fox Chase Cancer Center

OTHER

NCT02968732 - Cystoscopic Evaluation Predicting pT0 Urothelial Carcinoma of the Bladder | Biotech Hunter | Biotech Hunter